Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan;4(1):5-6.
doi: 10.1038/s43018-022-00505-8.

Two approaches to tackling COVID-19 in patients with blood cancer

Ratna Wijaya  1 , Sean H Lim  2
Affiliations
Comment

Two approaches to tackling COVID-19 in patients with blood cancer

Ratna Wijaya et al. Nat Cancer. 2023 Jan.
No abstract available

PubMed Disclaimer

Comment on

  • Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma.
    Keppler-Hafkemeyer A, Greil C, Wratil PR, Shoumariyeh K, Stern M, Hafkemeyer A, Ashok D, Hollaus A, Lupoli G, Priller A, Bischof ML, Ihorst G, Engelhardt M, Marks R, Finke J, Bertrand H, Dächert C, Muenchhoff M, Badell I, Emmerich F, Halder H, Spaeth PM, Knolle PA, Protzer U, von Bergwelt-Baildon M, Duyster J, Hartmann TN, Moosmann A, Keppler OT. Keppler-Hafkemeyer A, et al. Nat Cancer. 2023 Jan;4(1):81-95. doi: 10.1038/s43018-022-00502-x. Epub 2022 Dec 21. Nat Cancer. 2023. PMID: 36543907 Free PMC article.
  • Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial.
    Denkinger CM, Janssen M, Schäkel U, Gall J, Leo A, Stelmach P, Weber SF, Krisam J, Baumann L, Stermann J, Merle U, Weigand MA, Nusshag C, Bullinger L, Schrezenmeier JF, Bornhäuser M, Alakel N, Witzke O, Wolf T, Vehreschild MJGT, Schmiedel S, Addo MM, Herth F, Kreuter M, Tepasse PR, Hertenstein B, Hänel M, Morgner A, Kiehl M, Hopfer O, Wattad MA, Schimanski CC, Celik C, Pohle T, Ruhe M, Kern WV, Schmitt A, Lorenz HM, Souto-Carneiro M, Gaeddert M, Halama N, Meuer S, Kräusslich HG, Müller B, Schnitzler P, Parthé S, Bartenschlager R, Gronkowski M, Klemmer J, Schmitt M, Dreger P, Kriegsmann K, Schlenk RF, Müller-Tidow C. Denkinger CM, et al. Nat Cancer. 2023 Jan;4(1):96-107. doi: 10.1038/s43018-022-00503-w. Epub 2022 Dec 29. Nat Cancer. 2023. PMID: 36581734 Free PMC article. Clinical Trial.

References

    1. Keppler-Hafkemeyer, A. et al. Nat. Cancer https://doi.org/10.1038/s43018-022-00502-x (2022). - DOI
    1. Abbott, R. K. & Crotty, S. Immunol. Rev. 296, 120–131 (2020). - DOI
    1. Wratil, P. R. et al. Nat. Med. 28, 496–503 (2022). - DOI
    1. Lim, S. H. et al. Nat. Cancer 3, 552–564 (2022). - DOI
    1. Greenberger, L. M. et al. Blood Cancer Discov. 3, 481–489 (2022). - DOI

LinkOut - more resources